Overexpression of ANRIL in prostate cancer cells increased cell proliferation and migration by regulating the let-7a/TGFB1/Smad signaling pathway [62], demonstrating the potential molecular mechanism by which this lncRNA mediates cancer progression. This evidence concerns the gene CDKN2B-AS1 and prostate carcinoma.